Surendra Ajjarapu - Sep 1, 2022 Form 4 Insider Report for TRxADE HEALTH, INC (MEDS)

Role: CEO, Director, 10%+ Owner
Signature: /s/ Surendra K. Ajjarapu
Stock symbol: MEDS
Transactions as of: Sep 1, 2022
Transactions value $: $0
Form type: 4
Date filed: 9/16/2022, 04:57 PM
Previous filing: May 23, 2022
Next filing: Mar 28, 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MEDS	Common stock	Award	$0	+51.7K	+4.65%	$0.00	1.16M	Sep 1, 2022	Direct	F1, F2
holding	MEDS	Common stock						213K	Sep 1, 2022	Through Surendra Ajjarapu Revocable Trust of 2007 which Reporting Person controls as trustee
holding	MEDS	Common stock						675K	Sep 1, 2022	Through spouse
holding	MEDS	Common stock						213K	Sep 1, 2022	Through Sandhya Ajjarapu Revocable Trust of 2007 which Reporting Person controls as trustee

Showing 1 to 4 of 4 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares of Restricted Common Stock were issued to the Reporting Person pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan and are subject to forfeiture. The shares vest at the rate of 1/4 of the shares on September 30, 2022, October 31, 2022, November 30, 2022 and December 31, 2022, subject to the Reporting Person's continued service to the Company on such vesting dates, and subject to the terms and conditions of a Restricted Shares Grant Agreement entered into by and between the Issuer and the Reporting Person. Exempt under Rule 16b-3(d).
F2	Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as Chief Executive Officer.

Content

Shares of Restricted Common Stock were issued to the Reporting Person pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan and are subject to forfeiture. The shares vest at the rate of 1/4 of the shares on September 30, 2022, October 31, 2022, November 30, 2022 and December 31, 2022, subject to the Reporting Person's continued service to the Company on such vesting dates, and subject to the terms and conditions of a Restricted Shares Grant Agreement entered into by and between the Issuer and the Reporting Person. Exempt under Rule 16b-3(d).

Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as Chief Executive Officer.